Pembroke Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
Pembroke Management's RGEN Position: Q3 2026 in Review
Pembroke Management increased its Repligen (RGEN) stake by 37% in Q3 2026, buying an estimated $966K and bringing the position to 21,884 shares worth $4.21M. The position accounts for 0.52% of the portfolio, ranked #50.
Pembroke Management first reported a position in RGEN in Q2 2022 and has held it in 10 quarters since. The position peaked at $11.8M in Q4 2023. 277 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.
- Pembroke Management held 21,884 shares of Repligen worth $4.21M as of Q3 2026.
- Pembroke Management bought 5,941 Repligen shares in Q3 2026, an estimated $966K.
- Repligen made up 0.52% of Pembroke Management's portfolio in Q3 2026, its #50 holding.
- Pembroke Management first reported a position in Repligen in Q2 2022 and has held it in 10 quarters since.
- Pembroke Management's Repligen position peaked at $11.8M in Q4 2023.
- 277 funds tracked by Wall St. Rank held Repligen as of Q3 2026.
Based on Pembroke Management's 13F filing for Q3 2026, filed 21 Oct 2026.